Moreover, performing differential expression analysis comparing HPV-positive and HPV-negative HNSCC in the “Differential Analysis” tab confirms the well-established overexpression (p=8.74e-9) of CDKN2A (p16) in HPV-positive HNSCC14,15. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.